Private equity firm closes on Worldwide Clinical Trials deal
Private equity firm Kohlberg & Company has closed on its announced deal to take a majority ownership role in Triangle-based Worldwide Clinical Trials.
Read MorePosted by WRAL TechWire | Dec 12, 2023
Private equity firm Kohlberg & Company has closed on its announced deal to take a majority ownership role in Triangle-based Worldwide Clinical Trials.
Read MorePosted by WRAL TechWire | Aug 7, 2023
Triangle based Worldwide Clinical Trials, which has touted itself in the past as the “cure for the common CRO,” is being sold. It’s the latest life science services firm known as a contract research organization with Triangle roots to be sold.
Read MorePosted by Jason Parker | Jan 18, 2022
Worldwide Clinical Trials and Science 37, both newly arrived to the Triangle, will collaborate, the companies announced today.
Read MorePosted by WRAL TechWire | Jun 1, 2021
Worldwide Clinical Trials, recently was honored recently with five 2021 CRO Leadership Awards, Here are the details.
Read MorePosted by WRAL TechWire | Jan 21, 2021
The Frontier startup and innovation hub in RTP has a new firm in residence. And it’s hiring.
Read MorePosted by WRAL TechWire | Mar 16, 2018
Worldwide Clinical Trials, which touts itself as “the cure for the common CRO,” is growing.
Read More